SAN DIEGO, July 6, 2026 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced the pricing of its follow-on offering of 5,633,009 shares of its common…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
